CureFit had held discussions with SoftBank Vision Fund over a $200m investment, but Unilever Ventures has instead stepped up as part of a $120m round.
CureFit, an India-based healthcare and wellness services provider backed by UC-RNT Fund, has closed a $120m funding round that featured Unilever Ventures, the corporate venturing arm of consumer goods conglomerate Unilever, the Economic Times reported yesterday.
Financial services firm Kotak Mahindra Bank also took part in the round, as did Epiq Capital, Innoven Capital, Accel Partners, Kalaari Capital, Oaktree Capital and Chiratae Ventures, the venture capital firm formerly known as IDG Ventures India.
The round was filled out…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
